Alpha Paradigm Partners, LLC Nemaura Medical Inc. Transaction History

Alpha Paradigm Partners, LLC

  • $239 Million
  • Q4 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$5.76 - $9.95 $40,285 - $69,590
-6,994 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$4.7 - $16.7 $32,871 - $116,799
6,994 New
6,994 $72 Million

About Nemaura Medical Inc.

NMRD Quotes by TradingView
  • Ticker NMRD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,102,900
  • Description
  • Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...
More about NMRD
Track This Portfolio

Track Alpha Paradigm Partners, LLC Portfolio

Follow Alpha Paradigm Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Paradigm Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Paradigm Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email